Press Releases

AdvaMed, Medtech Leaders From Across the Country Meet with Lawmakers This Week

This week, more than 40 AdvaMed member company executives are meeting with lawmakers for a summer fly-in to discuss pressing issues for the medtech industry. The meetings, hosted by AdvaMed, the world’s largest trade association representing medical technology companies, give top medtech leaders the opportunity to meet with Congressional leaders on key committees and their staff on a wide range of policy issues, including MDUFA, diagnostic regulatory reform, SBIR/STTR reauthorization, and transitional coverage for emerging technologies (TCET).

“AdvaMed is committed to supporting our members as they work to develop innovative, life-saving medical technologies for patients, and one way we can do that is to connect them directly with their lawmakers and committee leadership who make decisions that broadly impact public health,” said Scott Whitaker, President and CEO of AdvaMed. “With the user fee authorization in its final stages and the possibility of Congressional action on critical programs that support early stage medtech companies, it is shaping up to be a pivotal year for patients. We look forward to continuing these meetings and urging Congress to support patients.”

One area of urgency for medtech leaders this week as they meet with lawmakers is the status of the MDUFA V agreement. Earlier this month, the Senate Health, Education, Labor and Pensions Committee passed S. 4348, the Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, which includes MDUFA V; concurrently, a similar version of the legislation passed the full of House of Representatives.

Additionally, key programs like the federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs are up for reauthorization this year and have long received bipartisan support. AdvaMed Accel, a division of AdvaMed that represents small and emerging-growth companies, is urging Congress to reauthorize the program before it expires on September 30th.

See a list of AdvaMed members’ policy priorities.

# # #


AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit